Annual Disclosure of eccumberances under Regulation 31(4) of SEBI(Substantial Acquisition of Shares and takeovers) regulation, 2011 for the year ended on 31-03-2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The promoters of Colinz Laboratories Ltd — Dr. Mani L.S. and Mrs. Vijaya Mani — have filed their annual encumbrance disclosure with BSE for the financial year ended 31 March 2025. In the letter, the promoters declare that they have not created any encumbrance (such as a pledge, lien, or charge) on their shareholding in the company, either directly or indirectly, during the year. The filing is a routine regulatory compliance requirement under SEBI's takeover regulations. No specific share quantities, pledge percentages, or changes in holdings are mentioned in the disclosure.
This is a routine compliance filing confirming promoters have not pledged or otherwise encumbered their shares during FY25 — a neutral, non-event for shareholders with no expected impact on stock price.